Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jun 20:4:83.
doi: 10.3389/fmed.2017.00083. eCollection 2017.

Current Therapeutic Approach to Hypertrophic Scars

Affiliations
Review

Current Therapeutic Approach to Hypertrophic Scars

Zrinka Bukvić Mokos et al. Front Med (Lausanne). .

Abstract

Abnormal scarring and its accompanying esthetic, functional, and psychological sequelae still pose significant challe nges. To date, there is no satisfactory prevention or treatment option for hypertrophic scars (HSs), which is mostly due to not completely comprehending the mechanisms underlying their formation. That is why the apprehension of regular and controlled physiological processes of scar formation is of utmost importance when facing hypertrophic scarring, its pathophysiology, prevention, and therapeutic approach. When treating HSs and choosing the best treatment and prevention modality, physicians can choose from a plethora of therapeutic options and many commercially available products, among which currently there is no efficient option that can successfully overcome impaired skin healing. This article reviews current therapeutic approach and emerging therapeutic strategies for the management of HSs, which should be individualized, based on an evaluation of the scar itself, patients' expectations, and practical, evidence-based guidelines. Clinicians are encouraged to combine various prevention and treatment modalities where combination therapy that includes steroid injections, 5-fluorouracil, and pulsed-dye laser seems to be the most effective. On the other hand, the current therapeutic options are usually empirical and their results are unreliable and unpredictable. Therefore, there is an unmet need for an effective, targeted therapy and prevention, which would be based on an action or a modulation of a particular factor with clarified mechanism of action that has a beneficial effect on wound healing. As the extracellular matrix has a crucial role in cellular and extracellular events that lead to pathological scarring, targeting its components mostly by regulating bone morphogenetic proteins may throw up new therapeutic approach for reduction or prevention of HSs with functionally and cosmetically acceptable outcome.

Keywords: hypertrophic scar; prevention; scar management; skin scarring; topical therapy; treatment; wound healing.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Clinical appearance of hypertrophic scar (HS) and keloid. (A) HSs on upper back that developed after excision of dermal nevi. (B) Close-up of HSs. (C) Chest of patient showing keloid developed spontaneously. (D) Close-up of keloid.

References

    1. Borthwick LA, Wynn TA, Fisher AJ. Cytokine mediated tissue fibrosis. Biochim Biophys Acta (2013) 1832:1049–60.10.1016/j.bbadis.2012.09.014 - DOI - PMC - PubMed
    1. Sen CK, Gordillo GM, Roy S, Kirsner R, Lambert L, Hunt TK, et al. Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen (2009) 17:763–71.10.1111/j.1524-475X.2009.00543.x - DOI - PMC - PubMed
    1. Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG. Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med (2011) 17:113–25.10.2119/molmed.2009.00153 - DOI - PMC - PubMed
    1. Bock O, Schmid-Ott G, Malewski P, Mrowietz U. Quality of life of patients with keloid and hypertrophic scarring. Arch Dermatol Res (2006) 297:433–8.10.1007/s00403-006-0651-7 - DOI - PubMed
    1. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev (2003) 83:835–70.10.1152/physrev.00031.2002 - DOI - PubMed